The dominant role of G12C over other KRAS mutation types in the negative prediction of efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in non–small cell lung cancer

Autor: Fiala, Ondrej, Pesek, Milos, Finek, Jindrich, Benesova, Lucie, Belsanova, Barbora, Minarik, Marek
Zdroj: In Cancer Genetics January-February 2013 206(1-2):26-31
Databáze: ScienceDirect